SCHEMBL4685281

SCHEMBL4685281

CCCN(CC1CCN(S(C)(=O)=O)CC1)C(C)Cc1cccc(N)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.54
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
DPP4 P27487 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
DPP9 Q86TI2 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
POLB P06746 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
RORC P51449 4/20 0.35
FABP6 P51161 1/20 0.34
TSHR P16473 1/20 0.34
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
CCR5 P51681 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4683873 0.88 CYP2D6 (0.55) CYP2D6ALDH1A1L3MBTL1DPP4DPP8
SCHEMBL8132866 0.85 CYP2D6 (0.51) CYP2D6ALDH1A1L3MBTL1RORCFABP6
SCHEMBL4682927 0.85 CYP2D6 (0.51) CYP2D6ALDH1A1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL4679793 0.85 CYP2D6 (0.51) CYP2D6ALDH1A1L3MBTL1RORCROCK2
SCHEMBL4678497 0.84 CYP2D6 (0.51) CYP2D6ALDH1A1POLBMEN1KMT2A
Hydrochloric Acid SCHEMBL4682009 0.84 CYP2D6 (0.50) CYP2D6ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4685609 0.83 CYP2D6 (0.49) CYP2D6ALDH1A1L3MBTL1POLBMEN1
Hydrochloric Acid SCHEMBL4682628 0.82 CYP2D6 (0.48) CYP2D6ALDH1A1L3MBTL1POLBMEN1
Hydrochloric Acid SCHEMBL4682834 0.82 CYP2D6 (0.48) CYP2D6ALDH1A1L3MBTL1POLBMEN1
SCHEMBL4679841 0.81 CYP2D6 (0.62) CYP2D6ALDH1A1L3MBTL1DPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1058680-B1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
US-6319920-B1 MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY SYNTEX (U.S.A.) LLC 2001-11-20 US disclosed
EP-1058680-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-12-13 EP disclosed
WO-1999043657-A1 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed